Kevin Elias, MD
Dr. Kevin Elias is an experienced physician-scientist with a demonstrated history of success in translational medicine and advanced oncologic care. He has years of experience in Medical Education, Clinical Trials & Healthcare Leadership for gynecologic oncology and early cancer detection. Graduating from Harvard College and Vanderbilt University School of Medicine, he completed his residency in […]
Amy P.N. Skubitz, Ph.D.
Amy P.N. Skubitz, Ph.D. is a Professor in the Department of Laboratory Medicine and Pathology at the University of Minnesota (UM) and an Adjunct Professor in the Department of Obstetrics, Gynecology, and Women’s Health. Dr. Skubitz serves as the Director of the Ovarian Cancer Early Detection Program (OCEDP) at the UM. Her research interests include […]
Elizabeth Garner, MD
Elizabeth Garner, MD, MPH has over a decade of pharmaceutical development experience. She also has deep expertise in clinical trial design and execution. She has held roles of increasing strategic responsibility in large and small companies, including ObsEva SA, Merck, Abbott (AbbVie), Myriad Genetics, and Agile Therapeutics. In addition to Pharm-Olam, she is also on […]
Prof. Uri Saragovi, PhD
Dr. Saragovi is a passionate and world-leading scientist in the area of Translational Medicine. Dr. Saragovi has published over 200 publications and 21 patents, primarily focusing translational medicine. More recently Dr. Saragovi has focused on the targeting of gangliosides, which are used clinically for cancer diagnosis, prognosis, and therapy. Dr. Saragovi based at McGill University […]